Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$113,880
New position
Shares Held
2,093
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#596
of 751 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantum Portfolio Management LLC holds $1,425,090 across 6 Biotechnology names. EXEL ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
807 | $400,861 | |
| 2 | ARGX |
Argenx SE
|
306 | $283,897 | |
| 3 | BNTX |
BioNTech SE
|
2,766 | $257,376 | |
| 4 | CAI |
Caris Life Sciences, Inc.
|
14,343 | $255,592 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
2,093 | $113,880 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
182 | $113,484 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,880 | 2,093 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||